台股 » 個股 » 和康生 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

和康生

(1783)
可現股當沖
  • 股價
    50.3
  • 漲跌
    ▼1.5
  • 漲幅
    -2.90%
  • 成交量
    219
  • 產業
    上市 生技醫療類股
  • 128人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
和康生 (1783)籌碼相關-玉山-台南 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

玉山-台南 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/07152.6000.0052.1011760.57%
2025/01/02249.0500.0049.0021371.46%
2024/12/2400.000.246.0547.00-0.2128-0.12%
2024/12/1800.000.146.5046.50-0.1130-0.04%
2024/12/1700.00047.2547.300129-0.03%
2024/12/1200.00148.9548.40-1126-0.79%
2024/12/1100.001.148.3448.65-1.1121-0.86%
2024/12/1000.00346.7846.70-3106-2.82%
2024/12/0500.00145.9546.00-1102-0.97%
2024/11/2900.00144.5544.60-1107-0.93%
2024/11/27143.80144.9043.7001090.00%
2024/11/25044.1500.0044.5501080.00%
2024/11/2100.00144.3043.70-1112-0.89%
2024/11/200.342.4000.0042.400.31060.28%
2024/10/2800.00143.5542.80-1138-0.72%
2024/10/2400.00342.1542.10-3144-2.07%
2024/10/16142.4000.0042.4012150.46%
2024/10/0700.00143.3043.50-1245-0.41%
2024/09/26242.500.142.7042.5023460.56%
2024/09/2500.00143.0543.20-1378-0.26%
2024/09/23142.1500.0042.1513850.26%
2024/09/18143.9000.0043.9013920.25%
2024/09/1600.00144.6544.50-1394-0.25%
2024/09/13144.3000.0044.2013970.25%
2024/09/04046.1500.0045.0004130.00%
2024/09/03046.5000.0046.1004130.00%
2024/08/2700.000.146.5546.50-0.1432-0.03%
2024/08/2300.00145.8546.10-1429-0.23%
2024/08/130.242.8500.0043.100.24250.04%
2024/08/06037.7500.0038.9504170.00%
2024/08/0500.000.138.6038.10-0.1412-0.02%
2024/07/220.146.8000.0046.500.13910.03%
2024/07/19247.7500.0046.5023840.52%
2024/07/1800.00147.4048.00-1346-0.29%
2024/07/1500.00144.7545.20-1331-0.30%
2024/07/1200.00144.9544.95-1329-0.30%
2024/07/09146.9000.0044.0513290.30%
2024/07/05249.80349.6349.40-1300-0.33%
2024/07/04149.4500.0049.5512950.34%
2024/07/021150.711150.3950.4002620.00%
2024/07/0100.00250.0050.20-2214-0.93%
2024/06/28046.0500.0046.2001840.01%
2024/06/1200.00144.9544.80-1157-0.64%
2024/06/1100.00245.9545.70-2157-1.27%
2024/06/06145.3000.0044.9011540.65%
2024/06/04845.5700.0044.3081495.34%
2024/05/281.241.97142.4042.550.21410.11%
2024/05/0700.00642.2042.45-6154-3.89%
2024/04/3000.00042.7042.900154-0.01%
2024/04/2900.00042.6042.600155-0.01%
2024/04/2200.00142.7042.35-1163-0.61%
2024/04/19142.0500.0042.0511630.61%
2024/04/1800.00243.8043.95-2158-1.26%
2024/04/1700.00443.7144.00-4159-2.51%
2024/04/16143.5500.0043.3511610.62%
2024/04/1000.00146.1046.10-1163-0.61%
2024/04/0100.000.346.5546.55-0.3166-0.18%
2024/03/29145.7000.0045.7011640.61%
2024/03/280.145.6500.0045.700.11660.06%
2024/03/270.245.9000.0045.800.21660.09%
2024/03/250.145.9000.0045.900.11660.06%
2024/03/19345.2200.0044.9031661.81%
2024/03/1400.00444.7845.65-4168-2.37%
2024/03/08644.6300.0044.7061683.56%
2024/03/04546.6500.0046.6051672.98%
2024/03/011.147.21547.5047.20-4167-2.35%
2024/02/270.348.002.147.9447.60-1.8178-1.01%
2024/02/26547.50247.6347.9031791.67%
2024/02/22047.5000.0047.5001830.00%
2024/02/20147.4000.0047.6011900.53%
2024/02/1600.00247.9047.95-2190-1.05%
2024/02/02147.30347.8047.30-2187-1.07%
〈大江集團法說〉和康生明年營收續拚雙位數成長 淨利率維持25%Anue鉅亨-2023/11/20
和康生三大業務銷售看旺 明、後年將啟動擴產計畫Anue鉅亨-2023/07/25
和康生全年毛利率有望維持67%水準 今年將取得10張認證Anue鉅亨-2023/05/23
和康生 相關文章